UBE2C Antibody - Primary antibody, specific to UBE2C, Rabbit IgG

Features and benefits
  • Short Overview:

    pAb; Rabbit anti Human UBE2C Antibody; WB, ICC, IF; Unconjugated

  • Species reactivity(Reacts with): Human,Mouse,Rat
  • Isotype: Rabbit IgG
    Application:
  • IF/ICC
  • WB
Item Number
Ab133227
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab133227-10μl
10μl
In stock
$59.90
Ab133227-20μl
20μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$89.90
Ab133227-50μl
50μl
In stock
$179.90
Ab133227-100μl
100μl
In stock
$279.90
Ab133227-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,999.90

pAb; Rabbit anti Human UBE2C Antibody; WB, ICC, IF; Unconjugated

Basic Description

Product NameUBE2C Antibody - Primary antibody, specific to UBE2C, Rabbit IgG
SynonymsCyclin selective ubiquitin carrier protein antibody|dJ447F3.2 antibody|Mitotic specific ubiquitin conjugating enzyme antibody|UB E2C antibody|UBCH 10 antibody|UbcH10 antibody|UBE 2C antibody|Ube2c antibody|UBE2C_HUMAN antibody|Ubiquitin carrier protein C
Specifications & PurityExactAb™, Validated, Carrier Free, High performance, Lot by Lot
Host speciesRabbit
SpecificityUBE2C
ImmunogenRecombinant UBE2C expressed in E.coli (AA 2-179).
Positive ControlWB: HeLa, A431, MCF7 and RAW 264.7 cell lysates. ICC/IF: HeLa cells.
ConjugationUnconjugated
GradeCarrier Free, ExactAb™, High Performance, Validated
Product Description

Rabbit anti Human UBE2C Antibody, Polyclonal, could be used for WB, ICC, IF and so on.
Application
· WB: 0.01-2μg/mL
· ICC/IF: 5-20μg/mL
Protein Function
Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'- and 'Lys-48'-linked polyubiquitination. Acts as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. Acts by initiating 'Lys-11'-linked polyubiquitin chains on APC/C substrates, leading to the degradation of APC/C substrates by the proteasome and promoting mitotic exit.

Product Properties

IsotypeRabbit IgG
SDS-PAGE150 kDa
Purification MethodAntigen affinity purified + Protein A purified
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4°C short term (1-2 weeks). Store at -20°C long term (24months). Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

UBE2C Antibody (Ab133227) - Western Blot
All lanes: UBE2C Antibody (Ab133227) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/10000 dilution

Predicted band size: 20 kDa
Observed band size: 17, 19 kDa
Exposure time: 5.0 s

UBE2C Antibody (Ab133227) - IF/ICC
FITC staining on IF
Samples: Human HeLa Cells
Primary Ab: 20 µg/mL UBE2C Antibody (Ab133227).

Associated Targets(Human)

UBE2C Tbio Ubiquitin-conjugating enzyme E2 C (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
UBE2C Tbio Ubiquitin-conjugating enzyme E2 C (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Application

ApplicationDilution info
WB

0.01-2 µg/mL

ICC/IF

5-20 µg/mL

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0404094Certificate of AnalysisApr 02, 2024 Ab133227
ZJ24F0404093Certificate of AnalysisApr 02, 2024 Ab133227
ZJ24F0404092Certificate of AnalysisApr 02, 2024 Ab133227

Related Documents

References

1. Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J.  (2001)  The DNA sequence and comparative analysis of human chromosome 20..  Nature,  414  (6866): (865-71).  [PMID:11780052]
2. Sharon Gauci,Andreas O Helbig,Monique Slijper,Jeroen Krijgsveld,Albert J R Heck,Shabaz Mohammed.  (2009-05-06)  Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach..  Analytical chemistry,  81  ((11)): (4493-4501).  [PMID:19413330]
3. Chen H, Wu G, Gao S, Guo R, Zhao Z, Yuan H, Liu S, Wu J, Lu X, Yuan X, Yu Z, Zu X, Xie N, Yang N, Hu Z, Sun Q, Zhang W..  (2017)  Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from α-Santonin Derivatives..  J Med Chem,  60  (16): (6828-6852).  [PMID:28696694]
4. Ni S, Chen X, Yu Q, Xu Y, Hu Z, Zhang J, Zhang W, Li B, Yang X, Mao F, Huang J, Sun Y, Li J, Jia L..  (2020)  Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth..  Eur J Med Chem,  185  (111848-111848).  [PMID:31732254]
5. Townsley, F M FM, Aristarkhov, A A, Beck, S S, Hershko, A A and Ruderman, J V JV..  (1997)  Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase..  Proceedings of the National Academy of Sciences of the United States of America,    (18):   [PMID:9122200]
6. Jin, Lingyan L, Williamson, Adam A, Banerjee, Sudeep S, Philipp, Isabelle I and Rape, Michael M..  (2008)  Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex..  Cell,    (16):   [PMID:18485873]
7. Garnett, Mathew J MJ and 7 more authors..  (2009)  UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit..  Nature cell biology,      [PMID:19820702]
8. Williamson, Adam A and 5 more authors..  (2009)  Identification of a physiological E2 module for the human anaphase-promoting complex..  Proceedings of the National Academy of Sciences of the United States of America,    (27):   [PMID:19822757]
9. David, Yael Y, Ziv, Tamar T, Admon, Arie A and Navon, Ami A..  (2010)  The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines..  The Journal of biological chemistry,    (19):   [PMID:20061386]
10. Rigbolt, Kristoffer T G KT and 9 more authors..  (2011)  System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation..  Science signaling,    (15):   [PMID:21406692]

Solution Calculators